Interferon-free HCV eradication after curative treatment of hepatocellular carcinoma Gastroenterologist of Tokyo university Outsiders (GTO) Study Group
Not Applicable
- Conditions
- HCV related HCC patients after curative treatment of HCC
- Registration Number
- JPRN-UMIN000022585
- Lead Sponsor
- Japanese Red Cross Medical Center
- Brief Summary
DAA treatment after HCC treatment was safe
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
Alergic for using drugs Decompaseted cirrhotic patients Not suitable for IFN free treatment Pregnant patients Not suitable for the treatment judged by Dr. in charge
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SVR of IFN free treatment after 24 weeks of treatment (SVR24)
- Secondary Outcome Measures
Name Time Method HCC reccurence Liver and kidney function Safety of treatment